A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer

Clinical trial NCT06760364 · RECRUITING

Trial details

NCT number: NCT06760364
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Pancreatic Cancers

Start date: 2024-12-25
Primary completion: 2027-12-24
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.